Literature DB >> 7814619

De novo synthesis and secretion of a 36-kD protein by cells that form lupus inclusions in response to alpha-interferon.

S A Rich1.   

Abstract

In response to the pure recombinant human alpha-IFN, IFLrA, Raji and Daudi were the only two cell lines among 19 human lymphoblastoid cell lines tested that formed the human lupus inclusions (LI) to a high frequency. Raji, Daudi, and five other cell lines were examined for protein changes that might accompany LI formation. Their selection was based upon T or B origin, association with Epstein-Barr virus, and ability to form LI. A trace protein of an estimated molecular mass of 36 kD (p36) and an isoelectric point of 5.6 was detected on two-dimensional gels only of alpha-IFN-treated Raji and Daudi cells. Gamma-IFN did not induce p36 or LI in any of these seven cell lines. In Daudi cells p36 and LI formed simultaneously in response to IFLrA, and persisted until the alpha-IFN-induced death of the culture. In Raji cells, p36 and LI appearance and disappearance coincided with the addition and removal of alpha-IFN. Fractionation of Raji cells with nonionic-detergent buffer placed p36 with the inclusions in the cytoplasmic supernatant. With detergent-free buffer p36 and LI were distributed evenly between the nuclear and cytoplasmic fractions. Pulse-chase experiments revealed that p36 was secreted. The de novo synthesis of p36 with alpha-IFN treatment was shown by labeling the cell proteins with [35S] methionine before and after the addition of alpha-IFN. These results along with previous results on the de novo synthesis of LI in the endoplasmic reticulum (which is involved in the processing and secretion of proteins) suggest a role for LI in the synthesis and secretion of p36.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814619      PMCID: PMC295410          DOI: 10.1172/JCI117643

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Internal sequence analysis of proteins separated on polyacrylamide gels at the submicrogram level: improved methods, applications and gene cloning strategies.

Authors:  P Tempst; A J Link; L R Riviere; M Fleming; C Elicone
Journal:  Electrophoresis       Date:  1990-07       Impact factor: 3.535

2.  Nature and origin of lupus-type inclusions.

Authors:  S A Rich; W E Gibbons
Journal:  Hum Pathol       Date:  1990-11       Impact factor: 3.466

3.  Evidence that the interferon-induced Daudi cell human lupus inclusions are de novo synthesized complexes of ribonucleoprotein and membrane.

Authors:  S A Rich; A A Reilly
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

4.  Fifty cases of human immunodeficiency virus (HIV) infection: immunoultrastructural study of circulating lymphocytes.

Authors:  W W Feremans; K Huygen; R Menu; C M Farber; J P de Caluwe; J P van Vooren; L Marcelis; L Andre; M Brasseur; H Bondue
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

5.  Ultrastructural markers in circulating lymphocytes of subjects at risk for AIDS.

Authors:  J M Orenstein; G L Simon; C M Kessler; R S Schulof
Journal:  Am J Clin Pathol       Date:  1985-11       Impact factor: 2.493

6.  Human lupus-type inclusions in umbilical cord blood mononuclear cells.

Authors:  S A Rich; W E Gibbons
Journal:  Arthritis Rheum       Date:  1990-09

7.  Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.

Authors:  P Matsudaira
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

8.  Purified recombinant human leukocyte interferons IFLrA and IFLrD induce human lupus inclusions in Raji and Daudi cells.

Authors:  S A Rich; T R Owens
Journal:  J Interferon Res       Date:  1984

9.  Induction of lupus inclusions by sera from patients with systemic lupus erythematosus.

Authors:  S A Rich; T R Owens; M C Anzola; L E Bartholomew
Journal:  Arthritis Rheum       Date:  1986-04

10.  Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor.

Authors:  M H Beresini; M J Lempert; L B Epstein
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

View more
  3 in total

1.  Kikuchi-Fujimoto Disease Masquerading as Metastatic Papillary Carcinoma of the Thyroid.

Authors:  Shailesh Garg; Manuel Villa; Jaya Ruth Asirvatham; Thomas Mathew; Louis-Joseph Auguste
Journal:  Int J Angiol       Date:  2015-06

2.  Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.

Authors:  Christopher P Larsen; Marjorie L Beggs; Mohammad Saeed; Patrick D Walker
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

Review 3.  Lupus pathobiology based on genomics.

Authors:  Mohammad Saeed
Journal:  Immunogenetics       Date:  2016-12-08       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.